Use of an immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system

Details for Australian Patent Application No. 2009334626 (hide)

Owner Laboratoire Francais du Fractionnement et des Biotechnologies

Inventors Elzaabi, Mazen

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009334626

PCT Pub. Number WO2010/076496

Priority 0807105 17.12.08 FR

Filing date 16 December 2009

Wipo publication date 8 July 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

11 August 2011 PCT application entered the National Phase

  PCT publication WO2010/076496 Priority application(s): WO2010/076496

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009334630-Method for detecting a bird or a flying object

2009334602-Regulated supply of treated water for regional supply networks